| abstract |
The invention provides for a pharmaceutical composition capable of modulating the androgen receptor comprising a compound of formula I n n n wherein the substitutents are as described herein. n Further provided are methods of using such compounds for the treatment of nuclear hormone receptor-associated conditions, such as age related diseases, for example sarcopenia. Also provided are pharmaceutical compositions containing such compounds and processes for preparing some of the compounds of the invention. |